Drug Monitoring 9 Panel W/ Conf, Urine

Last Modified: 9/22/2021 2:01:41 PM


Medical Necessity Documentation:  
Client Notes:  
Patient Preparation:  
Specimen Requirements: 30.0 mL Urine in a Green Clinical Drug Test Collection Cup
Collection Instructions:  
Minimum Volume: 7.0 mL Urine in a Green drug collection cup
Transport & Storage: Temperature/Stability: 5 days Ambient
7 days Refrigerated
30 days Frozen
Rejection Criteria: Preserved samples
Reference Range: Refer to Interpretive Results
Critical Ranges:  
Test Comments:  
Methodology: Screen: Immunoassay (IA); Confirmation: Mass Spectrometry (MS)
Clinical Significance: The management of patients use of controlled substances is an increasing focus of law enforcement to ensure that prescribed medications aren't diverted, and is critical to the successful outcome of many pharmaco-therapies.  Urine drug testing for the presence or absence of prescribed medications and illicit drugs is a strategy designed to help the treating physician monitor their patients for compliance with that physicians directive(s).
Documentation:  
Custom Panel: No

PRODUCTION SCHEDULE

Turn Around Time: 3 to 4 days
Days Performed: Sunday, Monday, Tuesday, Wednesday, Thursday, Friday, Saturday
Sites Performed: Quest - Chantilly
PHL Test Code: DMPU
EPIC Test Code: LAB3211
Send Out Test Code: 39422
Alternate Test Names: Drug Monitoring 9 Panel with confirmation, Urine; Drug Monitoring, Panel 1, with Confirmation, Urine; Prescription Drug Monitoring, Pain Management
Included Tests: Initial Screening; Amphetamines; Barbiturates; Benzodiazepines; Marijuana Metabolite; Cocaine Metabolite; Methadone Metabolite; Opiates; Oxycodone; Phencyclidine
CPT Coding: 80307

Go back to the top of the page.